Achieving Value in the Management of Chronic HCV Infection

05/04/17 • 15 min

Achieving value in the management of chronic HCV infection is one of the most complex challenges facing health plans today. Listen as AJ Ally, R.Ph, MBA, Vice President of Clinical Programs at DST’s Argus Health, talks about the balancing act between treating to cure and cost-effective management with a strategic focus on identifying and eliminating waste by using a Center of Excellence model to coordinate efforts of physicians, pharmacists and patients. Visit www.dsthealth.com to learn more. Sources CDC https://www.cdc.gov/hepatitis/hcv/hcvfaq.htmAASLD and IDSA Guidelines http://www.hcvguidelines.org/Kaiser Health News http://khn.org/news/medicaid-private-insurers-begin-to-lift-curbs-on-pricey-hepatitis-c-drugs/CDC https://www.cdc.gov/hepatitis/hcv/hcvfaq.htm

Previous Episode

Integrating Risk and Quality Management to Improve Outcomes and Optimize Revenue

MCOL, an industry leading publisher of healthcare news, interviewed DST’s risk adjustment expert Michael Nemeth about the challenges health plans face managing risk adjustment and quality performance and how integrating these two complex processes using an analytics platform can provide opportunities to impact health outcomes and optimize revenue. Download DST's latest white paper for more on how an advanced analytics platform can provide you with the transparency and continuous insights needed to understand member health, accurately document risk and make strategic decisions.

Next Episode

Readmissions-- What Health Plans Need to Know

A Readmission or re-hospitilization is when a patient returns to inpatient hospital care shortly after discharge, typically within 30 days of discharge. There are many reasons why readmissions are important; one of which is that they are exspensive. Preventing avoidable hospital readmissions is considered by many to be the most important opportunitiy for reducing waste in health care.